CDCynthia R. Driver

Cynthia R. Driver

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cynthia R. Driver has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 1 December 2010
      • Vol. 14  (12) , 1641-3

    Congenital tuberculosis and management of exposure in three neonatal intensive care units.

    by A Winters, T B Agerton, C R Driver, L Trieu, T O'Flaherty, S S Munsiff

    Congenital tuberculosis (TB) is uncommon, and diagnosis may be delayed. We report a case of congenital TB and the management of exposure in three different neonatal intensive care units. This case demonstrates the need for a high index of suspicion, active communication among maternal and neonatal medical providers, and timely provider reporting of maternal disease, and emphasizes the relatively greater risk of transmission to health care workers versus infants in this setting.


  • Molecular epidemiology of tuberculosis after declining incidence, New York City, 2001–2003

    by C. R. Driver, B. Kreiswirth, M. Macaraig, C. Clark, S. S. Munsiff, J. Driscoll, B. Zhao

    Tuberculosis incidence in New York City (NYC) declined between 1992 and 2000 from 51·1 to 16·6 cases per 100 000 population. In January 2001, universal real-time genotyping of TB cases was implemented in NYC. Isolates from culture-confirmed tuberculosis cases from 2001 to 2003 were genotyped using IS6110and spoligotype to describe the extent and factors associated with genotype clustering after declining TB incidence. Of 2408 (91·8%) genotyped case isolates, 873 (36·2%) had a pattern indistinguishable from that of another study period case, forming 212 clusters; 248 (28·4%) of the clustered cases had strains believed to have been widely transmitted during the epidemic years in the early 1990s in NYC. An estimated 27·4% (873 minus 212) of the 2408 cases were due to recent infection that progressed to active disease during the study period. Younger age, birth in the United States, homelessness, substance abuse and presence of TB symptoms were independently associated with greater odds of clustering.


  • Open Access

    Which Patients' Factors Predict the Rate of Growth of Mycobacterium tuberculosis Clusters in an Urban Community?

    by Cynthia R. Driver, Michelle Macaraig, Peter D. McElroy, Carla Clark, Sonal S. Munsiff, Barry Kreiswirth, Jeffrey Driscoll, Benyang Zhao

    Factors influencing tuberculosis cluster growth are poorly understood. The authors examined clusters of two or more culture-confirmed Mycobacterium tuberculosis cases between January 1, 2001, and December 31, 2003, that had insertion sequence 6110 (IS6110) restriction fragment length polymorphism and spoligotype patterns identical to those of another study case. Genotypes first seen in New York, New York, before or during 1993 were considered historical; recent strains were those first seen after 1993. The authors examined the effect of the combined characteristics of infectiousness of the first two cases in a cluster on the rate of cluster growth. Genotyping was performed for 2,408 (91.8%) of the 2,623 tuberculosis cases diagnosed; 873 cases were in 212 clusters. Thirty-one clusters had historical strains, 153 were recent, and 28 were of unknown period. Patients' infectiousness was not associated with the rate of cluster growth among historical strain clusters. Among recent strain clusters, infectiousness of both of the initial cases was associated with a higher rate of cluster growth compared with clusters in which neither initial case was infectious, upon adjustment for male sex (rate ratio = 2.62, 95% confidence interval: 1.19, 5.78). The rate of genotype cluster growth should be monitored regardless of how long the strain has been present in the community. However, infectiousness in the first two cases may be useful to prioritize genotype cluster investigations.


  • Tuberculosis in health care workers during declining tuberculosis incidence in New York State

    by Cynthia R. Driver, Rachel L. Stricof, Karen Granville, Sonal S. Munsiff, Galina Savranskaya, Cheryl Kearns, Athalia Christie, Margaret Oxtoby


  • Open Access

    Effectiveness of Isoniazid Treatment for Latent Tuberculosis Infection among Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Injection Drug Users in Methadone Programs

    by Jerod N. Scholten, Cynthia R. Driver, Sonal S. Munsiff, Katherine Kaye, Mary Ann Rubino, Marc N. Gourevitch, Caroline Trim, James Amofa, Randy Seewald, Esther Highley, et al.

    Injection drug users (IDUs) were heavily affected by the tuberculosis (TB) resurgence in New York City in the 1990s. We assessed the effectiveness of


    • 1 December 2003
      • Vol. 7, S432-8

    Contact investigations in congregate settings, New York City.

    by C R Driver, M K Balcewicz-Sablinska, Z Kim, J Scholten, S S Munsiff

    Large urban tuberculosis control program. To evaluate results of procedures implemented for systematic investigation of tuberculosis exposures in congregate settings. Between October 1995 and December 2000, a unit consisting of epidemiologists, health educators and tuberculin screening staff investigated exposures in sites with >15 persons. Transmission at the site was defined as likely, possible, unlikely or unknown. Among 100 investigations, 12 were tuberculosis case clusters, five were source case investigations, and 83 were exposures to single infectious cases. Transmission was likely in 24 (21%), possible in eight (8%), unlikely in 62 (62%), and could not be assessed in four (4%). Among the 83 exposures to single infectious cases, 2740 contacts were tested; 502 (18%) were infected. Among 1202 close contacts, 996 (82%) were tested, 197 (20%) were infected and started treatment of latent tuberculosis infection (LTBI) and 102/197 (52%) completed treatment. Sites with likely transmission had index patients with longer duration of cough (13 vs. 6 weeks, P = 0.01) and cavitary lesions (84% vs. 44%, P = 0.01) compared to sites with unlikely transmission. A systematic approach for conducting contact investigations in congregate settings is useful for assessing transmission. As such investigations are resource intensive and transmission is not common, performing tuberculin skin testing after most persons would have converted should be considered in low-risk groups. Additional efforts are needed to increase completion of treatment for LTBI in contacts identified in these settings.


  • Targeting Tuberculosis Testing: The Yield of Source Case Investigations for Young Children with Reactive Tuberculin Skin Tests

    by C. R. Driver

    This study was designed to determine the yield of investigations whose aim is to identify a source case for tuberculosis infection among tuberculin reactors 3 years of age or younger. The authors describe the results of associate investigations conducted for child tuberculin reactors reported from January 1, 1996, through June 30, 1998. Associates were defined as individuals who live with or spend significant time with a child reactor. An associate investigation was defined as evaluation of at least one associate. A source case was an associate older than 10 years of age who had culture-positive, pulmonary tuberculosis during a period when the child could have been exposed. Two hundred seven children had an associate investigation performed with a median of four associates investigated per child (range 1-21). Birthplace was known for 187 (90%); 128 were U.S.-born. Of 1,222 associates identified, 980 (80%) were evaluated. Among 452 (46%) associates for whom birthplace was known, 250 (55%) were non-U.S.-born. Of 980 associates, 668 were household contacts; 198 (30%) were infected, three had prior tuberculosis disease, and three had active tuberculosis. Two active cases met source case criteria; the yield was 0.9 (2 of 207) source cases per 100 children investigated. Of 312 non-household contacts, 57 (18%) were infected and none had the disease. Although few source cases were identified for young tuberculin skin test reactors in New York City, investigations identified a proportion of cases and infection in associates similar to that identified among contacts to pulmonary tuberculosis cases. Such investigations may be identifying a high-risk group and should be considered, depending on program resources.


    • 1 March 2002
      • Vol. 6  (3) , 238-45

    Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion.

    by V Sundaram, P I Fujiwara, C R Driver, S S Osahan, S S Munsiff

    New York City. To evaluate the yield of continued monthly sputum monitoring after culture conversion. A retrospective review of tuberculosis patients verified between 1 January 1995 and 31 December 1996 who had: 1) pulmonary tuberculosis with organisms susceptible to isoniazid and rifampin; 2) culture conversion; and 3) completed therapy. We assessed time to smear and culture conversion and number of persons who developed a positive culture after culture conversion (culture reversion). Of 1440 patients, 379 were cared for by tuberculosis control program providers and 1061 were cared for by other providers; 813 (56%) were initially smear-positive. After the fifth month, 44 (5.3%) were smear-positive; four of these were culture-positive. Eighteen (1.3%) had culture reversions; eight were smear-positive. Excluding one specimen per patient collected at treatment completion, 7967 sputum samples were collected after culture conversion. The minimum estimated cost per culture reversion detected was $26,557. Continued monthly monitoring of sputum after culture conversion identified a very small number of patients who had culture reversion. However, patients who cannot tolerate or adhere to a standard regimen may need continued monitoring to assess response to treatment. For all patients a specimen should be collected at the end of treatment to document cure.


  • Open Access

    Relapse in Persons Treated for Drug‐Susceptible Tuberculosis in a Population with High Coinfection with Human Immunodeficiency Virus in New York City

    by Cynthia R. Driver, Sonal S. Munsiff, Jiehui Li, Nicole Kundamal, Sukhminder S. Osahan

    The optimal duration of tuberculosis treatment for persons infected with human immunodeficiency virus (HIV) has been debated. A cohort of 4571 cultur


    • 14 January 1999
      • Vol. 13  (1) , 149-50

    Tuberculosis treatment practices in the era of protease inhibitors: a provider survey.

    by V Sundaram, C R Driver, S S Munsiff